Apr 23 |
After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX)
|
Apr 22 |
Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX)
|
Apr 11 |
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
|
Apr 1 |
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call Transcript
|
Mar 28 |
Earnings Scheduled For March 28, 2024
|
Mar 27 |
OptimizeRx Earnings Preview
|
Mar 25 |
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
|
Mar 22 |
OptimizeRx: Exponential Growth Drives The Valuation Cheaper
|
Mar 11 |
OptimizeRx provides update on the timing of earnings call
|
Mar 11 |
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
|